Atwood & Palmer Inc Abb Vie Inc. Transaction History

Atwood & Palmer Inc

$1.3 Billion
Q2 2024

A detailed history of Atwood & Palmer Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Atwood & Palmer Inc holds 194,246 shares of ABBV stock, worth $37.6 Million. This represents 2.56% of its overall portfolio holdings.

Number of Shares

194,246

Previous 190,431 2.0%

Holding current value

$37.6 Million

Previous $34.7 Million 3.92%

% of portfolio

2.56%

Previous 2.66%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	BUY	$154.79 - $180.76 $590,523 - $689,599	3,815 Added 2.0%	194,246 $33.3 Million
Q1 2024 Apr 10, 2024	BUY	$159.82 - $182.1 $179,637 - $204,680	1,124 Added 0.59%	190,431 $34.7 Million
Q4 2023 Jan 12, 2024	SELL	$137.6 - $154.97 $61,782 - $69,581	-449 Reduced 0.24%	189,307 $29.3 Million
Q3 2023 Oct 20, 2023	BUY	$133.59 - $154.65 $70,802 - $81,964	530 Added 0.28%	189,756 $28.3 Million
Q2 2023 Jul 18, 2023	BUY	$132.51 - $164.9 $416,743 - $518,610	3,145 Added 1.69%	189,226 $25.5 Million
Q1 2023 Apr 21, 2023	BUY	$144.61 - $166.54 $219,951 - $253,307	1,521 Added 0.82%	186,081 $29.7 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $300,547 - $360,435	2,173 Added 1.19%	184,560 $29.8 Million
Q3 2022 Oct 12, 2022	BUY	$134.21 - $153.93 $335,525 - $384,825	2,500 Added 1.39%	182,387 $24.5 Million
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $2.37 Million - $3.02 Million	17,251 Added 10.61%	179,887 $27.6 Million
Q1 2022 Apr 29, 2022	BUY	$131.98 - $163.75 $450,711 - $559,206	3,415 Added 2.14%	162,636 $26.4 Million
Q4 2021 Jan 24, 2022	BUY	$107.43 - $135.93 $87,877 - $111,190	818 Added 0.52%	159,221 $21.6 Million
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $816,407 - $926,744	7,673 Added 5.09%	158,403 $17.1 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $1.18 Million - $1.31 Million	11,184 Added 8.01%	150,730 $17 Million
Q1 2021 Apr 26, 2021	BUY	$102.3 - $112.62 $184,140 - $202,716	1,800 Added 1.31%	139,546 $15.1 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $814,639 - $1.1 Million	10,121 Added 7.93%	137,746 $14.8 Million
Q3 2020 Oct 28, 2020	BUY	$85.91 - $100.83 $124,655 - $146,304	1,451 Added 1.15%	127,625 $11.2 Million
Q2 2020 Jul 24, 2020	BUY	$73.37 - $98.18 $9.05 Million - $12.1 Million	123,364 Added 4390.18%	126,174 $12.4 Million
Q1 2020 Apr 20, 2020	BUY	$64.5 - $97.79 $19,995 - $30,314	310 Added 12.4%	2,810 $214,000
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $46,710 - $57,606	-600 Reduced 19.35%	2,500 $230,000
Q2 2018 Jul 19, 2018	SELL	$89.78 - $106.23 $112,225 - $132,787	-1,250 Reduced 28.74%	3,100 $287,000
Q1 2018 Apr 30, 2018	SELL	$92.01 - $123.21 $36,804 - $49,284	-400 Reduced 8.42%	4,350 $412,000
Q2 2017 Aug 08, 2017	BUY	N/A	4,750	4,750 $344,000

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwood & Palmer Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atwood & Palmer Inc with notifications on news.

Account

Atwood & Palmer Inc Abb Vie Inc. Transaction History